"MedImmune" Ushers In New Era Of Patent Litigation

Law360, New York (January 12, 2007, 12:00 AM EST) -- In its January 9, 2007 decision, the U.S. Supreme Court got 2007 off to a roaring start with its eagerly anticipated decision in MedImmune, Inc. v. Genentech, Inc. Although its full impact will not be known for several years as lower courts grapple with the decision, MedImmune could profoundly affect the way in which patent owners license their technology in the future and also promises a significant amount of additional litigation relating to both existing and future license agreements.

The case resolves a relatively discrete constitutional...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.